AstraZeneca News — every source, one live feed
Track AstraZeneca news in real time — Anglo-Swedish pharmaceutical company with major oncology, cardiovascular, and rare disease franchises.. fllwup^ collects the latest AstraZeneca headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest AstraZeneca headlines
- AstraZeneca fends off lawsuit over alleged Soliris drug monopoly — Reuters
- AstraZeneca, Alexion’s myasthenia gravis treatment enters crowded market — Endpoints News
- Rhythm Pharma: Is AstraZeneca/Eli Lilly's Bidding War For Real? Don't Rule It Out (RYTM) — Seeking Alpha
- AstraZeneca’s sonesitatug vedotin BLA accepted for priority review — The Pharma Letter
- AstraZeneca Bet $2 Billion on Summit’s Cancer Drug. The FDA Just Said Not Yet. — Barron's
- With Klygefa approvals, AZ expands myasthenia gravis domain beyond Soliris, Ultomiris — Fierce Pharma
- Tempus AI and AstraZeneca Extend Strategic Services Agreement — TipRanks
- AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy — Reuters
- AstraZeneca Cuts 600 US Sales Staff as Savings Drive Kicks In — Bloomberg
- AstraZeneca buys partner Omniose for bacterial vaccine technology — Fierce Biotech
Follow AstraZeneca live on fllwup^ · Follow in any RSS reader — or browse all topics.
More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.